Adalimumab

Today 's guidance recommending the use of adalimumab will ensure adults with severe psoriasis are able to access a treatment of proven benefit .

目前推荐使用阿达木单抗的治疗方针将确保患有严重银屑病的成人能得到确切疗效的治疗。

OBJECTIVE : To determine potential differences in clinical responses , soluble drug levels and antibody formation between patients with RA receiving infliximab and adalimumab .

目的：研究接受英夫利西单抗和阿达木单抗治疗的风湿性关节炎患者，确定他们之间的临床反应、溶解药物浓度以及抗体形成的差异。

The National Institute for Health and Clinical Excellence ( NICE ) has published guidance on the use of adalimumab for the treatment of psoriasis in adults .

英国国家临床推荐治疗方案研究所发布了阿达木单抗治疗成人银屑病的用药方针。

BACKGROUND : Adalimumab has proven efficacious in the treatment of active ankylosing spondylitis , and is approved in Europe and the US for the treatment of active , established AS .

背景：已有研究证实阿达木能有效治疗活动性强直性脊柱炎，在欧洲和美国已获批治疗活动性、明确诊断的AS患者。